One study demonstrated that BPC-157 treatment resulted in significantly higher load to failure in healed tendons compared to controls
What the preclinical safety data shows The preclinical safety profile of the BPC-157 sequence, which is identical in PDA, is remarkably clean
the present invention furthermore relates to a BPC peptide salt or a pharmaceutical or diagnostic composition according to the above wherein the general formula (II) is the present invention relates in particular to a BPC peptide salt or a pharmaceutical or diagnostic composition a BPC peptide salt or a pharmaceutical or diagnostic composition comprising a salt of a BPC peptide according to the above general formula (I) wherein the peptide is selected from the group consisting of: the peptides may be linked to other functional and/or structural moieties such as carbohydrates, fats, proteins or peptides, antibodies, receptors, hormones, cytotoxic substances, marker substances, dyes, radioactive labels, immunomodulatory agents, drugs, carriers, targeting or signalling substances, etc
A deficiency in B12 can lead to symptoms such as fatigue, weakness, memory problems, and neurological issues
